Example: biology

Corporate Overview Presentation January 2022

Jan 10, 2022 · adagrasib (MRTX849), sitravatinib, MRTX1133 and MRTX1719 is a forward-looking statement and should be considered an at-risk statement. Such statements are subject to risks and uncertainties, particularly those challenges

Tags:

  Forward

Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Transcription of Corporate Overview Presentation January 2022

Related search queries